Respiratory allergy (e.g., hay fever) - Symptoms, Causes, Treatment & Prevention

```html Respiratory Allergy (Hay Fever) – Comprehensive Guide

Respiratory Allergy (Hay Fever) – A Complete Patient Guide

Overview

Respiratory allergy, commonly called hay fever or allergic rhinitis, is an immune‑system reaction to airborne substances (allergens) such as pollen, mold spores, animal dander, or dust mites. When a sensitized person inhales these particles, the body releases histamine and other chemicals, causing inflammation of the nasal passages, sinuses, and sometimes the eyes and throat.

Who it affects: Anyone can develop respiratory allergies, but they are most prevalent in children and young adults. Women are slightly more likely than men to be diagnosed (approximately 55% vs. 45%).

Prevalence: According to the World Health Organization (WHO) and the American College of Allergy, Asthma & Immunology, allergic rhinitis affects 10‑30% of the global population, with up to 25% of school‑age children reporting symptoms each year. In the United States, the CDC estimates that more than 60 million adults and children suffer from some form of respiratory allergy.

Symptoms

Symptoms vary with the type of allergen, season, and individual sensitivity. They typically appear shortly after exposure (minutes to a few hours) and may persist as long as the allergen is present.

Upper‑respiratory symptoms

  • Sneezing – sudden, repetitive fits.
  • Runny nose – clear, watery discharge.
  • Congestion – feeling of blockage, often worsened at night.
  • Itchy nose or palate – a tingling sensation that triggers rubbing.

Ocular (eye) symptoms

  • Itchy, watery eyes (allergic conjunctivitis).
  • Redness and mild swelling of the eyelids.

Throat and ear symptoms

  • Itchy or sore throat from post‑nasal drip.
  • Ear fullness or mild itching due to eustachian tube irritation.

Systemic or less common symptoms

  • Fatigue – chronic congestion can disturb sleep.
  • Headache – sinus pressure.
  • Cough – dry or productive cough triggered by airway irritation.
  • Asthma exacerbation – wheezing or shortness of breath in patients with co‑existing asthma.

Causes and Risk Factors

Primary causes (allergens)

  • Pollen – trees (spring), grasses (late spring‑summer), weeds (late summer‑fall).
  • Mold spores – indoor (e.g., basements) and outdoor (wet seasons).
  • Dust mites – tiny insects that thrive in bedding, upholstered furniture, and carpets.
  • Animal dander – proteins found in skin flakes, saliva, and urine of pets.

Risk factors

  • Family history – having parents or siblings with allergies raises risk 2‑3×.
  • Personal atopy – eczema, food allergies, or allergic asthma increase susceptibility.
  • Environmental exposure – living near farms, high‑pollen regions, or in homes with heavy carpet/dust‑mite burden.
  • Smoking or second‑hand smoke – irritates the nasal mucosa and amplifies allergic response.
  • Air pollution – PM2.5 and ozone can worsen nasal inflammation.
  • Age – peak onset is 5‑30 years; symptoms often improve after age 50 but can persist.

Diagnosis

Accurate diagnosis combines a detailed history, physical examination, and, when needed, specific allergy testing.

Clinical evaluation

  • Review of symptom pattern (seasonality, triggers, duration).
  • Physical exam of nasal mucosa, eyes, and throat; looking for pale, boggy turbinates or allergic shiners.

Allergy testing

  1. Skin prick test (SPT) – A small amount of standardized allergen is introduced into the skin; a wheal ≄3 mm after 15 minutes is considered positive. Sensitivity >90%, specificity ~85% (Mayo Clinic).
  2. Serum specific IgE test (e.g., ImmunoCAP) – Measures IgE antibodies to particular allergens; useful when skin testing is contraindicated.
  3. Intracutaneous test – Similar to SPT but uses larger volumes, reserved for ambiguous cases.

Additional investigations (when indicated)

  • Nasopharyngoscopy – visualizes nasal polyps or structural issues.
  • CT scan of sinuses – for chronic sinusitis suspicion.
  • Peak flow monitoring – in patients with concurrent asthma.

Treatment Options

Management is individualized, aiming to reduce exposure, control symptoms, and improve quality of life.

1. Allergen avoidance (environmental control)

  • Keep windows closed during high‑pollen days; use air‑conditioners with HEPA filters.
  • Shower and change clothes after outdoor activities.
  • Wash bedding weekly in hot water (>130 °F) to kill dust mites.
  • Use allergen‑impermeable pillow and mattress covers.
  • Reduce indoor humidity < 50% to limit mold growth.

2. Medications

Intranasal corticosteroids (first‑line)

Most effective for nasal congestion, itching, and rhinorrhea.

  • Examples: Fluticasone propionate, Budesonide, Mometasone.
  • Onset of relief: 12‑24 hours; full effect in 1‑2 weeks.
  • Safety: Minimal systemic absorption; mild nasal irritation possible.

Antihistamines

Useful for sneezing, itching, and watery eyes.

  • Second‑generation (e.g., Cetirizine, Loratadine, Fexofenadine) – non‑sedating, preferred for daytime use.
  • First‑generation (e.g., Diphenhydramine) – cause drowsiness; reserved for nighttime or acute episodes.

Intranasal antihistamines

Azelastine or Olopatadine combine antihistamine and mild anti‑inflammatory effects; fast onset (15‑30 min).

Decongestants

Oral (pseudoephedrine) or topical (oxymetazoline) – effective for short‑term relief of severe congestion.

  • Limit use to ≀3‑5 days to avoid rebound congestion (rhinitis medicamentosa).

Lewis‑type immunotherapy (Allergy shots)

Gradual introduction of increasing allergen doses over 3‑5 years to induce tolerance.

  • Indicated for patients with moderate‑to‑severe disease unresponsive to medication.
  • Reduces need for medications by 30‑50% in many studies (Cleveland Clinic).

Subcutaneous or sublingual immunotherapy tablets

Standardized tablets (e.g., grass‑pollen SLIT) taken daily at home; similar efficacy to injections with a better safety profile for selected allergens.

3. Adjunctive therapies

  • Saline nasal irrigation – isotonic or hypertonic spray/kettle rinse to clear mucus and allergens; safe for daily use.
  • Montelukast (Leukotriene receptor antagonist) – Helpful when asthma co‑exists or for aspirin‑sensitive patients.
  • Biologic agents (e.g., Omalizumab) – Reserved for severe, refractory allergic rhinitis with comorbid asthma; reduces IgE levels.

Living with Respiratory Allergy (Hay Fever)

Daily management tips

  • Morning routine: Nasal saline rinse, then apply intranasal steroid spray before leaving home.
  • Medication schedule: Keep a pillbox; set alarms for twice‑daily steroid use.
  • Environmental monitoring: Subscribe to local pollen forecasts (e.g., National Allergy Bureau). Stay indoors when pollen counts are >50 grains/mÂł.
  • Clothing strategy: Wear sunglasses outdoors to reduce eye exposure; choose breathable fabrics and wash after outdoor exposure.
  • Pet care: Bathe pets weekly, keep them out of bedrooms, and use HEPA vacuums.
  • Home cleaning: Vacuum with a HEPA filter, mop floors, and dust with a damp cloth to avoid aerosolizing allergens.
  • Air quality: Use a portable air purifier in the bedroom; replace HVAC filters every 3 months.
  • Travel planning: Research destination pollen seasons; pack medications and a travel-sized saline rinse.

When to adjust treatment

If symptoms persist despite consistent use of intranasal steroids, consider adding an oral antihistamine, switching to a combined intranasal steroid/antihistamine spray, or discussing immunotherapy with your allergist.

Prevention

While you cannot eliminate the genetic predisposition, you can greatly lower the frequency and severity of episodes.

  1. Early life exposure: Breastfeeding for ≄3 months and exposure to diverse microbial environments (e.g., farms) may reduce atopy risk (NIH).
  2. Avoid smoking during pregnancy and in the child's environment.
  3. Control indoor humidity (<50%) to prevent dust‑mite and mold proliferation.
  4. Regular cleaning using HEPA vacuums, washing bedding, and minimizing carpeted areas.
  5. Vaccination: Keep flu and pneumococcal vaccines up to date; respiratory infections can aggravate allergic rhinitis.
  6. Education: Teach children how to recognize early symptoms and practice proper hand‑washing to avoid secondary infections.

Complications

If left untreated or poorly controlled, respiratory allergy can lead to several downstream problems:

  • Chronic sinusitis – persistent inflammation can cause sinus blockage, bacterial infection, and facial pressure.
  • Otitis media – eustachian tube dysfunction may result in middle‑ear infections, especially in children.
  • Sleep disturbances – Nasal congestion leads to snoring, obstructive sleep‑apnea, or poor sleep quality, affecting daytime performance.
  • Asthma worsening – Allergic rhinitis is a major risk factor for developing asthma or for asthma exacerbations.
  • Reduced quality of life – Studies show that moderate‑to‑severe allergic rhinitis can impair work productivity and academic performance comparable to chronic conditions like diabetes.

When to Seek Emergency Care

Warning signs that require immediate medical attention:
  • Sudden swelling of the lips, tongue, or throat (angioedema).
  • Difficulty breathing, wheezing, or a feeling of tightness in the chest.
  • Rapid drop in blood pressure causing dizziness or fainting.
  • Severe hives (urticaria) covering large areas of the body.
  • Persistent, severe headache or vision changes that could suggest sinus thrombosis (very rare).

If any of these symptoms occur, call 911** or go to the nearest emergency department immediately. Anaphylaxis, though uncommon with hay fever alone, can happen when a respiratory allergen is combined with food or insect‑venom allergies.

References

  • American College of Allergy, Asthma & Immunology. Allergic Rhinitis. 2023.
  • Mayo Clinic. Allergic rhinitis (hay fever) – Symptoms & causes. Updated 2024.
  • Cleveland Clinic. Allergy shots (Immunotherapy). 2022.
  • Centers for Disease Control and Prevention. National Health Interview Survey – Allergy Data. 2023.
  • World Health Organization. Global prevalence of allergic rhinitis. 2022.
  • National Institutes of Health. Early life exposures and atopic disease. 2021.
```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.